Skip to Main Content
Sophie Chu
Sophie Chu

Sophie Chu

Counsel
Hong Kong
+852.2230.3517
Email Sophie Chu @ Sophie.Chu@klgates.com
Download V-Card
Download Sophie Chu PDF (English)

Sophie Chu is counsel in the firm’s Corporate Mergers and Acquisitions (M&A) practice group. Sophie focuses her practice on M&A (public and private), strategic alliances, joint ventures and divestitures. On the capital markets front, she works with various listing applicants and sponsors in relation to proposed initial public offerings on stock exchanges in Hong Kong, Taiwan and the US, as well as high-yield bond offering projects. She also assists investors, funds and emerging growth companies with venture capital financing, loans and investments.

Sophie works closely with companies in Greater China region in various sectors including technology, semiconductor, financial services, real estate, energy and life sciences. She regularly assists clients with general corporate and compliance matters as well as cross-border international trade issues. She initially started her career as a litigator in the United States and has experience resolving cross-border commercial disputes, including litigation, arbitration (ICC and HKIAC) and mediation.

Prior to joining the firm, Sophie served as senior counsel in the Hong Kong office of another international law firm. Sophie also has in-house counsel experience and was previously seconded to the Global Procurement Department of a major international bank.

Earlier in her career, she spent four years in a large Taiwanese Law firm focusing on company listings, cross-border M&A and general corporate matters. She also practiced in the United States for two and half years, mainly engaging in commercial and international litigation.

  • Speaker, “GC Summit Taiwan 2023: Anti-Money Laundering and Sanctions–What International Business Need to Know,” Legal 500, 2023
  • Speaker, “International Company and Commercial Law Review," Nanjing Jiangbei New Area High-end Forum, 2019
  • Speaker, "Developing a Road Map for Efficient Due Diligence for Acquiring IP Assets in the Life Sciences, Pharma and Medical Device Fields in the U.S.," Nanjing Biological Medicine Industry Innovation & Development Forum, 2017
  • Speaker, “Compliance with the US Foreign Corrupt Practices Act, the UK Bribery Act and Other Anti-Corruption Laws Applicable to the International Marketplace,” The Hong Kong Institute of Certified Public Accountants, 2015
  • Speaker, "How Chinese and American Law Firms Can Collaborate on IP Cases in Multiple Jurisdictions," Guangzhou Lawyer Organization, 2015
  • Speaker, "IP Annual Conference 2012: Improving Disclosure and Confidentiality Agreements Involving Intellectual Property and Other Sensitive Information," Mysipo, 2012
  • Co-Author, "The 2010 Guide to Private Equity and Venture Capital: Taiwan’s Changing Face," IFLR, October 2010
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel